Mohammed Basulaiman
Saudi Arabia
Research Article
Cost of Diabetes in the Kingdom of Saudi Arabia, 2014
Author(s): Ali H Mokdad, Marwa Tuffaha, Michael Hanlon, Charbel El Bcheraoui, Farah Daoud, Mohammad Al Saeedi, Ahmad A Alrasheedy, Mohammad A Al Hussein, Ziad A Memish, Mohammed Basulaiman, Mohammad A AlMazroa and Abdullah A Al RabeeahAli H Mokdad, Marwa Tuffaha, Michael Hanlon, Charbel El Bcheraoui, Farah Daoud, Mohammad Al Saeedi, Ahmad A Alrasheedy, Mohammad A Al Hussein, Ziad A Memish, Mohammed Basulaiman, Mohammad A AlMazroa and Abdullah A Al Rabeeah
Objective: Diabetes mellitus is a major burden in the Kingdom of Saudi Arabia (KSA). We estimated the direct cost of diabetes in KSA and the future cost accounting for currently undiagnosed and borderline diabetics. Methods: We used a bottom-up approach to determine the direct cost of diabetes mellitus in KSA at the population level using Saudi Ministry of Health (MOH) cost data for medications, health visits, laboratories, and hospitals. We used Saudi Health Interview Survey (SHIS) national data to estimate the number of people categorized as gestational, those with borderline diabetes (glucose intolerant), diagnosed, undiagnosed, controlled, and uncontrolled diabetics. Results: We estimate that the current cost of diabetes is at 17 billion Riyals. We also estimate that if those who are undiagnosed joined the treatment pool, the future cost would increase to 27 billion Riyals. Moreov.. View More»
